Suppr超能文献

电休克治疗期间琥珀酰胆碱的药物相互作用。

Succinylcholine drug interactions during electroconvulsive therapy.

作者信息

Marco L A, Randels P M

出版信息

Biol Psychiatry. 1979 Apr;14(2):433-45.

PMID:476229
Abstract

Electroconvulsive therapy (ECT) is frequently described as being almost free of absolute contraindications. However, drug interactions with succinylcholine pose potential hazards to which this paper calls attention. In addition to its neuromuscular-blocking action, succinylcholine has other acetylcholine-like effects. Drugs which inhibit cholinesterase activity or which inhibit acetylcholine release or synthesis may produce prolonged respiratory paralysis when combined with succinylcholine. The increasing longevity of the population receiving chemotherapy for physical ailments implies that greater numbers of these patients may also become candidates for ECT and therefore be at risk for adverse drug interactions with succinylcholine. Of particular importance to the psychiatrist are the various psychotropic drugs that have been reported to interact with succinylcholine. Precautions in using drug combinations and treatment of complications are described.

摘要

电休克疗法(ECT)通常被描述为几乎没有绝对禁忌证。然而,药物与琥珀酰胆碱的相互作用会带来潜在危害,本文对此予以关注。除了其神经肌肉阻滞作用外,琥珀酰胆碱还有其他类似乙酰胆碱的作用。抑制胆碱酯酶活性、抑制乙酰胆碱释放或合成的药物与琥珀酰胆碱合用时,可能会导致呼吸麻痹延长。因身体疾病接受化疗的人群寿命延长,这意味着更多此类患者可能也会成为ECT的候选对象,因此有与琥珀酰胆碱发生药物不良相互作用的风险。对精神科医生尤为重要的是,已有报告称多种精神药物会与琥珀酰胆碱相互作用。文中描述了使用药物组合的注意事项及并发症的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验